StonvexLoading…
StonvexStonvexStonvexCore line items from CALY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $614.51M | $687.50M | $2.06B | $462.60M | $600.40M |
Operating Income | Not available | $138.20M | $128.10M | $4.80M | $74.30M |
Net Income | Not available | $93.10M | $-409.30M | $-14.70M | $20.30M |
EPS (Diluted) | $0.33 | $0.47 | $-2.20 | $-0.08 | $0.11 |
Total Assets | Not available | $3.18B | $7.29B | $7.57B | $7.61B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $499.50M | $903.20M | $865.60M | $683.50M |
Free Cash Flow OCF − CapEx | Not available | $-176.00M | $302.20M | $59.50M | $-102.60M |
Shares Outstanding | Not available | 202.70M | 185.70M | 185.20M | 184.30M |